WO2017193458A1 - Organosilicone modified acrylic polyester potassium salt and preparation method and use in prevention and treatment of cancer - Google Patents
Organosilicone modified acrylic polyester potassium salt and preparation method and use in prevention and treatment of cancer Download PDFInfo
- Publication number
- WO2017193458A1 WO2017193458A1 PCT/CN2016/087162 CN2016087162W WO2017193458A1 WO 2017193458 A1 WO2017193458 A1 WO 2017193458A1 CN 2016087162 W CN2016087162 W CN 2016087162W WO 2017193458 A1 WO2017193458 A1 WO 2017193458A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- silicone
- modified acrylic
- potassium
- deionized water
- potassium salt
- Prior art date
Links
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 title claims abstract description 41
- 229920000728 polyester Polymers 0.000 title claims abstract description 27
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 title claims abstract description 24
- 206010028980 Neoplasm Diseases 0.000 title claims abstract description 22
- 238000002360 preparation method Methods 0.000 title claims abstract description 9
- 201000011510 cancer Diseases 0.000 title claims description 20
- 230000002265 prevention Effects 0.000 title description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims abstract description 45
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims abstract description 44
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 32
- 239000008367 deionised water Substances 0.000 claims abstract description 27
- 229910021641 deionized water Inorganic materials 0.000 claims abstract description 27
- 239000003814 drug Substances 0.000 claims abstract description 23
- 230000036541 health Effects 0.000 claims abstract description 16
- 150000002148 esters Chemical class 0.000 claims abstract description 13
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 claims abstract description 12
- USHAGKDGDHPEEY-UHFFFAOYSA-L potassium persulfate Chemical compound [K+].[K+].[O-]S(=O)(=O)OOS([O-])(=O)=O USHAGKDGDHPEEY-UHFFFAOYSA-L 0.000 claims abstract description 10
- 229920001296 polysiloxane Polymers 0.000 claims description 23
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 claims description 11
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 claims description 11
- -1 potassium salt silicon propane salt Chemical compound 0.000 claims description 7
- POXCVKMBBFNXLZ-UHFFFAOYSA-N propane;silicon Chemical compound [Si].CCC POXCVKMBBFNXLZ-UHFFFAOYSA-N 0.000 claims description 5
- 238000007259 addition reaction Methods 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 230000002045 lasting effect Effects 0.000 claims description 3
- 235000013373 food additive Nutrition 0.000 claims description 2
- 239000002778 food additive Substances 0.000 claims description 2
- 238000000034 method Methods 0.000 claims description 2
- 238000005303 weighing Methods 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 27
- 229910001385 heavy metal Inorganic materials 0.000 abstract description 21
- 229940079593 drug Drugs 0.000 abstract description 17
- 231100000783 metal toxicity Toxicity 0.000 abstract description 2
- 241000282414 Homo sapiens Species 0.000 description 44
- 150000003839 salts Chemical class 0.000 description 31
- 239000000126 substance Substances 0.000 description 19
- 108090000623 proteins and genes Proteins 0.000 description 15
- 210000004211 gastric acid Anatomy 0.000 description 13
- 230000006870 function Effects 0.000 description 11
- 238000006243 chemical reaction Methods 0.000 description 9
- 230000029142 excretion Effects 0.000 description 9
- 210000004940 nucleus Anatomy 0.000 description 9
- 210000002784 stomach Anatomy 0.000 description 9
- 201000010099 disease Diseases 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 230000006378 damage Effects 0.000 description 7
- 241000282412 Homo Species 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 235000013305 food Nutrition 0.000 description 5
- 230000004060 metabolic process Effects 0.000 description 5
- 229910052751 metal Inorganic materials 0.000 description 5
- 239000002184 metal Substances 0.000 description 5
- 231100000957 no side effect Toxicity 0.000 description 5
- 229910052760 oxygen Inorganic materials 0.000 description 5
- 238000010521 absorption reaction Methods 0.000 description 4
- 229910052799 carbon Inorganic materials 0.000 description 4
- 230000005611 electricity Effects 0.000 description 4
- 239000007789 gas Substances 0.000 description 4
- 230000005855 radiation Effects 0.000 description 4
- 239000002699 waste material Chemical group 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 208000005718 Stomach Neoplasms Diseases 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 230000002354 daily effect Effects 0.000 description 3
- 238000005265 energy consumption Methods 0.000 description 3
- 206010017758 gastric cancer Diseases 0.000 description 3
- 239000005416 organic matter Substances 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 201000011549 stomach cancer Diseases 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical class [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 230000001066 destructive effect Effects 0.000 description 2
- 238000001784 detoxification Methods 0.000 description 2
- 230000037406 food intake Effects 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 208000032839 leukemia Diseases 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 125000003367 polycyclic group Chemical group 0.000 description 2
- ZUBIJGNKOJGGCI-UHFFFAOYSA-M potassium;prop-2-enoate Chemical group [K+].[O-]C(=O)C=C ZUBIJGNKOJGGCI-UHFFFAOYSA-M 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 229910052710 silicon Inorganic materials 0.000 description 2
- 239000010703 silicon Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 238000009423 ventilation Methods 0.000 description 2
- 239000002912 waste gas Substances 0.000 description 2
- 108091005508 Acid proteases Proteins 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 208000005623 Carcinogenesis Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010016100 Faeces discoloured Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- 208000018737 Parkinson disease Diseases 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000000184 acid digestion Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 150000001491 aromatic compounds Chemical class 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000000476 body water Anatomy 0.000 description 1
- 150000005693 branched-chain amino acids Chemical class 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000036952 cancer formation Effects 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002091 carbon monoxide Inorganic materials 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000002925 chemical effect Effects 0.000 description 1
- 125000003636 chemical group Chemical group 0.000 description 1
- 230000035606 childbirth Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 230000002498 deadly effect Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 230000000423 heterosexual effect Effects 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000000266 injurious effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229940042040 innovative drug Drugs 0.000 description 1
- 239000010805 inorganic waste Substances 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000008141 laxative Substances 0.000 description 1
- 230000002475 laxative effect Effects 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000002101 lytic effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- 150000002826 nitrites Chemical class 0.000 description 1
- 230000008689 nuclear function Effects 0.000 description 1
- 230000005658 nuclear physics Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 239000010815 organic waste Substances 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 231100000719 pollutant Toxicity 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 235000002639 sodium chloride Nutrition 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 210000000515 tooth Anatomy 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
- C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
- C08F220/04—Acids; Metal salts or ammonium salts thereof
- C08F220/06—Acrylic acid; Methacrylic acid; Metal salts or ammonium salts thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/80—Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
- C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
- C08F220/10—Esters
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Definitions
- the invention belongs to the field of biomedicine and relates to a health care product, in particular to a silicone modified acrylic polyester potassium salt, a preparation method thereof and a cancer prevention and cancer treatment application.
- S is a flexible base.
- S is formed by the accumulation of photons in the nucleus (especially the H nucleus), providing energy to actuate the protons and then promoting the atomic reaction and then returning to the reduced photons, so it is a viable life-type basis.
- H nucleus has only one electron cloud and one electron, so it is most easy to generate S in the H nucleus.
- Photons are also easy to enter C, O, and N nucleuses (there are only two layers of electron clouds in the nucleus, and there are few electrons), so it is easy to promote nuclear, and it can also generate S to further promote nuclear.
- Human life genetic elements metabolism.
- the organic matter in the human body loses the child due to the lapse of time, and loses the flexibility.
- the space-like organic matter is rich in raw seeds due to the photonucleus, so the human body can be replaced by the same kind of substance, and the flexibility is regulated.
- photons (mass 0) are not charged but can be attached with micro-charges. Therefore, the accumulation of photons into the nucleus can form a cumulative micro-charge of the living beings to promote the nuclear function, but how much micro-energy is accumulated by the S-subjects needs to be verified by humans.
- This theory proposes the principles of organic chemistry, inorganic chemistry, biochemistry, nuclear physics and chemistry to finally explore the fundamental basis of life genes (atoms, protons, electrons, neutrons, children, photons). In order to achieve scientific control and effective results.
- the direction of human drug innovation is based on no side effects or reduce side effects, followed by targeted improvement effect.
- the stomach is the digestive system of the human body. Normal people must eat a lot of animals and plants for a long time. It is the first and most important part of the daily complex chemical reaction of the human body. Therefore, it should be understood that it is very effective and often has the most side effects. This is the reason why human cancer has the highest rate of cancer in cancer.
- the stomach is lysed in foods with large acid value (pH ⁇ 1 ⁇ 2) and oxygen-rich state.
- the main components of normal chemical cleavage should be:
- Amino acids (mostly alpha, beta), which are absorbed or excreted by the body's main nutrients;
- Carbon dioxide (O combined with pyrolytic activated carbon), detoxification, will be vented.
- Cancer is an uncontrollable foreign body protein. At present, it is generally believed that the factors of gastric cancer production are mainly caused by the ingestion of organic amines, nitrites, aromatic compounds, molds and the like. This kind of poison does cause abnormal carcinogenesis of the stomach, but from its chemical point of view, the reaction result is not 100% destructive, and it is not comparable to the side effects of heavy metal salts of gastric acid.
- the chemical direction of acid and metal salt is fixed.
- the salt formed by gastric acid and heavy metal is polycyclic multi-branched salt and large nuclear energy salt. It can quickly destroy the gastric acid digestion function and is not easy to metabolize. Once it is ultra-micro or time-long, it is a cause. There is no doubt that heavy metals enter the stomach.
- the human ecological environment is due to the huge daily energy consumption of human beings, which also leads to waste gas residue. There are not many days and times. The biggest evil result is that there are unpredictable heavy metals scattered on the ground every day. Animals and plants and water sources absorb – and finally enter the human body in large quantities.
- the principle of controlling human health is to ensure the comprehensive chemical and physical balance of water, electricity and gas, so destroying this kind of balance means harming the human body. Obviously, if the human body touches a chemical that is too active or too rigid, it will cause death. This has been confirmed many times by human tragedies. Living: bacteria infection, active organic amines, cyanide salts, etc., it can quickly destroy the reaction of human body catalyzed biological enzymes, resulting in rapid loss of control of human metabolism and death; over the dead: that is heavy metal actives, uncontrollable metabolism, long-term must Killed.
- the most injurious type of dead plate type is Pb salt and As salt.
- the compound genes are not only fixed and too high to be metabolized, but also multi-ring and multi-branched are more likely to form unsuitable multiple adverse reaction results.
- a branch is a ⁇ COO ⁇ chain formed by binding to gastric acid protease, the result is equivalent to bacterial destruction, and it is not easy to metastasize, and gastric cancer can be formed relatively quickly;
- this type of branch is mostly based on amino acids, can be stagnant in the stomach or transfer absorption, transfer to the intestine, liver, gallbladder, kidney to form the destruction gene, accumulate into cancer;
- the molecular weight of the branched chain amino acid is small, the flow activity is high, and it is easy to transfer into the blood and the lungs, forming a cancer there;
- this kind of amino acid salt can be clearly identified as organic amine salt, so once it enters the bloodstream, it can increase several types of white blood cells and is not easy to replace, forming leukemia, which is the rapid increase rate of leukemia in human proximal stage;
- arsenic salt seems to be more destructive than lead salt, but it is not. It is known that human metabolism must be released by human beings. In general, photons are not easy to enter the heavy metal core of multi-layer electron cloud to promote nuclear, but Once accumulated, the nuclear radiation will form. C, H, O organic matter is easy to suck and give birth to children, and it is easy to enter the lead nucleus when the body is stuffy for a long time, forming deadly nuclear radiation!
- lead is the primary pollutant that currently harms human health. Humans must be given special control.
- drugs are essential for human survival.
- the world due to the rapid development of society, the world has created a lot of edible drugs, which have made many contributions to the treatment of diseases and save people. It is undeniable.
- the harm caused by many drugs after human consumption sexual side effects are also growing, and attention should be paid to control!
- the invention believes that how to scientifically control the safe and sequelae of food safety and the effective therapeutic function should be discussed in the following three aspects.
- the main structure of chemical drugs should be based on stable non-lytic type to reduce other side effects.
- the chemical drug branch structure can be introduced into special therapeutic balance components according to different causes to achieve therapeutic purposes. Since the main chain is harmless and easy to excrete, even if there is an unpredictable abnormality, side effects sequelae can be avoided or reduced.
- controllable drugs should be used immediately and try to avoid side effects.
- the present invention provides a silicone-modified acrylic polyester potassium salt, a preparation method thereof, and a cancer prevention and cancer treatment use, the silicone-modified acrylic polyester potassium salt and
- the preparation method and the anti-cancer and cancer-treating use are to solve the technical problems of the side effects of the drugs or health care products for preventing and treating cancer in the prior art which have large side effects and are not effective.
- the invention provides a silicone modified acrylic polyester potassium salt prepared from acrylic acid or its esters, propylene silicone, potassium persulfate, isopropanol, potassium hydroxide and deionized water.
- the mass ratio of its ester, propylene silicone, potassium persulfate, isopropanol, potassium hydroxide and deionized water is 15.0 to 20.0: 0.7 to 2.0: 0.3 to 1.0: 6.0 to 10.0: 8.0 to 15.0: 52.0 to 70.0.
- the invention also provides a preparation method of the above-mentioned silicone modified acrylic polyester potassium salt,
- the present invention also provides the use of the above-mentioned silicone-modified acrylic polyester potassium salt in the preparation of a medicament or a health care product for treating or preventing cancer.
- the present invention also provides the use of the above-mentioned silicone-modified acrylic polyester potassium salt as a food additive.
- the invention also provides a medicine or a health care product, which is composed of the above-mentioned silicone-modified acrylic polyester potassium salt, isopropyl alcohol and deionized water, wherein the silicone-modified acrylic polyester potassium salt silicon propane salt Percentage of mass It is 5.0%, the isopropanol is 1.0 to 2.0%, and the deionized water is 93.0 to 94.0%.
- the invention also provides a medicine or a health care product, which is composed of the above-mentioned silicone-modified acrylic polyester potassium salt and deionized water, wherein the mass percentage of the silicone-modified acrylic polyester potassium salt silicon propane salt At 5.0%, the deionized water was 95.0%.
- the prevention and treatment principle of the present invention is:
- Main structure Polypropylene chain, stable performance, difficult to crack and change, it is harmless, and its soft and hard properties, adhesion smoothness and other functions can be adjusted through different components. It is not easy to crack and absorb in the human body, but it can absorb a variety of organic wastes due to organic compounds and long-chain factors - such as in vivo food, benzene, organic carbon and other waste gas, waste residue, the main function is physical absorption cooperation. Excretion efficiency of wastes with inorganic wastes;
- X active silicone - Si (OH) 3 , Si (OCH 3 ) 3 , the efficacy of this product.
- Active silicone branch, active silicone can directly react with free metal ions, can also adsorb reactive oxide metal, and can displace the reaction to adsorb gastric acid metal salts, which is the unique physical and chemical effect of its active silicone.
- the branch component can avoid the control of gastric acid heavy metal salt forming gene, and can also adsorb or replace gastric acid heavy metal salt excretion, which is the scientific controllable reason for the anti-cancer and cancer treatment of the present invention.
- active silicones are essential materials for human body (mostly from wheat bean food), which can effectively control minerals.
- the effective function of ingesting minerals is to control the overall balance of water, electricity and gas.
- potassium hydroxide KOH trace, pH of 7.0 ⁇ 7.5, no side effects
- the salt is caused by the cleavage of a trace amount of K 2 S 2 O 8 , the human body can be eaten with a salt medicine (a laxative), and there is no side effect.
- the technical progress of the present invention is remarkable compared to the prior art. It has become increasingly clear that heavy metals are extremely harmful to humans! The main reason is that the formation of gastric acid heavy metal salts in the stomach has led to the current multi-gene gene for human cancer. Faced with the current reality, how to control the dangers of heavy metals should be a clear direction for human drug control.
- the silicone-modified acrylic polyester potassium salt of the present invention can control heavy metal toxicity, thereby rapidly preventing cancer and having a health care function.
- FT-2016 an active silicone modified acrylic polyester potassium salt (referred to as silicon propane salt), from acrylic acid or its esters, propylene silicone, potassium persulfate (reagent, pharmaceutical grade), isopropanol (reagent, Prepared by drug grade), potassium hydroxide (reagent, drug grade) and deionized water.
- the mass ratio of the acrylic acid or its ester, propylene silicone, potassium persulfate, isopropanol, potassium hydroxide and deionized water is 15.0 to 20.0: 0.7 to 2.0: 0.3 to 1.0: 6.0 to 10.0: 8.0. 15.0: 52.0 to 70.0.
- Synthesis method first add deionized water and isopropanol to a reactor for heating, preheat to 65-75 ° C, add 5 ⁇ 15% K 2 S 2 O 8 , then heat to 78 ⁇ 85 ° C, start adding acrylic acid Or its esters, propylene silicone and 70-80% K 2 S 2 O 8 , lasting 1 to 2 hours, adding the remaining K 2 S 2 O 8 after the dropwise addition reaction, and keeping the temperature 1 to 2 at 85-90 ° C After an hour, then cool to 65-75 ° C, add KOH to adjust the pH value of 7.0-8.0, then open at 65-75 ° C for 1 to 2 hours, then continue to cool to 30 ⁇ 50 ° C, and filter to obtain FT-2016.
- FT-2016A FT-2016, isopropanol and deionized water were weighed by mass percentage, and the mass percentage was: silicon propyl salt 5.0%, isopropyl alcohol 1.0-2.0%, deionized water 93.0-94.0%.
- FT-2016 isopropanol and deionized water were weighed by mass percentage, and the mass percentage was: silicon propyl salt 5.0%, isopropyl alcohol 1.0-2.0%, deionized water 93.0-94.0%.
- FT-2016B Weigh FT-2016 and deionized water by mass percentage, the mass percentage is: silicon propyl salt 5.0%, deionized water 95.0%. Firstly, FT-2016 is baked in a heater at 85-90 ° C for 1 to 2 hours to form a powdery silicon propane salt, which is obtained by adding deionized water.
- FT-2016 (FT-2016A, FT-2016B) has been used in many places (Shanghai, Guangdong, Hong Kong, Taiwan, Japan, etc.) for nearly half a year. (drink 5ml / 3 ⁇ 7 days)
- the stomach has a heterosexual disease: rapid excretion of dark black stool (multi-metal), the gram is a sense of overall comfort, more and more healthy, significantly treatment and preventive effects;
- Parkinson's disease restore dietary excretion, sleep ventilation, sacral bones and other conditions
- tube cerebral infarction rapid recovery of sleep, excretion, ventilation, activities and other effects, a little longer (January to February) that is to lose weight, reduce high blood pressure, high fat and other original symptoms;
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Disclosed are an organosilicone modified acrylic polyester potassium salt and a preparation method therefor. The organosilicone modified acrylic polyester potassium salt is prepared from an acrylic acid or esters thereof, acrylic organosilicone, potassium persulfate, isopropanol, potassium hydroxide and deionized water, wherein the mass ratio of the acrylic acid or esters thereof to acrylic organosilicone to potassium persulfate to isopropanol to potassium hydroxide to deionized water is 15.0 - 20.0 : 0.7 - 2.0 : 0.3 - 1.0 : 6.0 - 10.0 : 8.0 - 15.0 : 52.0 - 70.0. The organosilicone modified acrylic polyester potassium salt can be used in the preparation of drugs or health care products for treating or preventing cancers, and can control the heavy metal toxicity, and thus can quickly prevent and treat cancers and has a health care effect.
Description
本发明属于生物医药领域,涉及一种保健品,具体来说是一种有机硅改性丙烯酸聚酯钾盐及制备方法和防癌治癌用途。The invention belongs to the field of biomedicine and relates to a health care product, in particular to a silicone modified acrylic polyester potassium salt, a preparation method thereof and a cancer prevention and cancer treatment application.
(一)、一种新基子S子——生子(生命基子)(1) A new type of sub-S - child (life base)
S子是一种灵活基子。S is a flexible base.
S子由光子辐射原子核中(尤其是H核子)积累形成,提供能量促动中质子然后促进原子反应后又复回减量光子,因此它是一种可生可辞的生命型基子。S is formed by the accumulation of photons in the nucleus (especially the H nucleus), providing energy to actuate the protons and then promoting the atomic reaction and then returning to the reduced photons, so it is a viable life-type basis.
光子最易进入H核子(H原子核仅一层电子云一枚电子),故最易在H原子核中生成S子。Photons are most likely to enter the H nucleus (H nucleus has only one electron cloud and one electron), so it is most easy to generate S in the H nucleus.
光子也易进入C、O、N核子(原子核均仅二层电子云,电子也少),所以容易促核,也能生成S子进一步促核。Photons are also easy to enter C, O, and N nucleuses (there are only two layers of electron clouds in the nucleus, and there are few electrons), so it is easy to promote nuclear, and it can also generate S to further promote nuclear.
人类生存主要影响原子如下:The main factors affecting human survival are as follows:
自然界生物起源:纯H2O、CO2状态,光子辐射H粒子生成生子→促动H质子→促动H电子→H2O微电裂解→与CO2结合→形成自然界初生有机碳水化合物→以后逐步生成植物→动物、人类。Nature's biological origin: pure H 2 O, CO 2 state, photon radiation H particles generate protons → mobilize H protons → actuate H electrons → H 2 O microelectrolysis → bind with CO 2 → form natural primary organic carbohydrates → later Gradually produce plants → animals, humans.
这就是自然界生物生成起源,光核辐射是自然生物之首要物理化学源素,S子是特要生成基子!This is the origin of the biological origin of nature, photonuclear radiation is the primary source of physical chemistry of natural organisms, S is a special generation of base!
人类生命基因要素:新陈代谢。人体内有机物因历时便失去生子,失去灵活性,空间同类有机物则因光核富含生子,所以人体食入该同类物质即可置换,调控灵活性。Human life genetic elements: metabolism. The organic matter in the human body loses the child due to the lapse of time, and loses the flexibility. The space-like organic matter is rich in raw seeds due to the photonucleus, so the human body can be replaced by the same kind of substance, and the flexibility is regulated.
这就是C、H、O、N可形成有机化学生命体的生存要在,这其中S子就是生命基This is where C, H, O, and N can form an organic chemical life, where S is the life base.
子。特要说明:光子(质量为0)本身不带电但可附微电荷,故光子入原子核累积可形成生子累积微电荷以起促核功效,但S子累积多少微能量尚须人类以后探讨验证。child. Special note: photons (mass 0) are not charged but can be attached with micro-charges. Therefore, the accumulation of photons into the nucleus can form a cumulative micro-charge of the living beings to promote the nuclear function, but how much micro-energy is accumulated by the S-subjects needs to be verified by humans.
(二)、综合化学(一套探讨生命基因新理论)(B), comprehensive chemistry (a set of new theory of life genes)
本理论提出综合有机化学、无机化学、生物化学、核物理化学等原理,以最终综合生命基因物质分子根本基子(原子核、质子、电子、中子、生子、光子)方可探索生命基因根本基理,以达科学可控有效之果。This theory proposes the principles of organic chemistry, inorganic chemistry, biochemistry, nuclear physics and chemistry to finally explore the fundamental basis of life genes (atoms, protons, electrons, neutrons, children, photons). In order to achieve scientific control and effective results.
一、综合化学(人体生成基因探讨)基理:First, comprehensive chemistry (exploration of human genes):
光核作用→生子功效→原子爱德华效应→原子结合→有机化学反应→形成分子基因。Photon nuclear action → childbirth effect → atomic Edwardian effect → atomic binding → organic chemical reaction → formation of molecular genes.
二、控制人体健康要理:水、电、气综合化学物理平衡。Second, to control human health: water, electricity, gas, comprehensive chemical and physical balance.
三、人类药物创新方向:首要为基无副作用或减少副作用,其次妨为针对性提高正
作用。Third, the direction of human drug innovation: the first is based on no side effects or reduce side effects, followed by targeted improvement
effect.
四、深刻认识目前因日逐大量能耗造致环境污染的严重危害性,人类应加强团结再团结日逐引起共同重视并日逐加强共同防范。真正救人类:防患在前,治病在后!Fourth, profound understanding of the serious harm caused by environmental pollution caused by a large amount of energy consumption per day. Humanity should strengthen unity and reunification, and cause common concern and strengthen joint prevention. Really save humanity: prevent the disease before, cure the disease!
(三)、人类现时癌症首要多发基因——胃酸重金属盐(3) The most common gene for cancer in humans - the heavy metal salt of gastric acid
胃是人体消化系统,正常者每日必须食入不少动植物延生,正是人体每日大量复杂化学反应首处和最大处。所以应该明白,其正作用很大,往往副作用也最大。人类现时癌症以胃癌率最高即说明此原因。The stomach is the digestive system of the human body. Normal people must eat a lot of animals and plants for a long time. It is the first and most important part of the daily complex chemical reaction of the human body. Therefore, it should be understood that it is very effective and often has the most side effects. This is the reason why human cancer has the highest rate of cancer in cancer.
胃是在酸值较大(PH≈1~2)以及富氧状态裂解食物的,其正常化学裂解主要成份应为:The stomach is lysed in foods with large acid value (pH ≈1~2) and oxygen-rich state. The main components of normal chemical cleavage should be:
氨基酸(多为α、β型),为人体主要营养吸取或排泄;Amino acids (mostly alpha, beta), which are absorbed or excreted by the body's main nutrients;
有机酸、碳水化合物、盐、水,为人体需要吸收或排泄;Organic acids, carbohydrates, salt, and water are needed to be absorbed or excreted by the body;
二氧化碳(O与裂解活性碳结合),排毒作用,必泄。Carbon dioxide (O combined with pyrolytic activated carbon), detoxification, will be vented.
无疑胃脏本身及消化反应后其主要化学功能物即是——羧基(-COOH),羧基易与金属反应后成盐,特地说明如下:It is undoubted that the main chemical function of the stomach itself and after the digestion reaction is - carboxyl (-COOH), and the carboxyl group is easily reacted with the metal to form a salt, which is specifically described as follows:
1、与钾、钠形成负一价盐。小、细、活,对人体水、电、气导流灵活,易代谢排泄;1. Form a negative monovalent salt with potassium and sodium. Small, fine, live, flexible to the human body water, electricity, gas, easy to metabolic excretion;
2、与钙、铁形成负二价盐,中、细、尚活,为人体骨骼等提供适度韧性及提供红血球,又可代谢,天意万年安排人生;2, with calcium, iron to form a negative divalent salt, medium, fine, still alive, to provide moderate toughness and provide red blood cells for human bones, but also metabolism, God wants to arrange life for thousands of years;
3、与重金属形成高负价盐(≥2),大、粗、固,不易代谢排泄。不可否认,人体必需摄入微量重金属以坚韧牙、骨、筋等器质以及其他健生功能,但更应明白,重金属盐固化性实在太高,并且还潜伏一定辐射能,所以一旦超微量其后遗症必定重大致命。3, with heavy metals to form high negative salt (≥ 2), large, thick, solid, difficult to metabolic excretion. It is undeniable that the human body must ingest a small amount of heavy metals to toughen teeth, bones, tendons and other health functions, but it should be understood that the heavy metal salt is too solid, and it also lurks certain radiant energy, so once it is ultra-micro sequela Must be fatal.
癌症是人体不可控异物体蛋白质。目前普遍认为胃癌生成因素主要是食入有机胺、亚硝酸盐、芳烃化合物、霉菌等造致。该类毒物确实会造致胃脏异常致癌,但从其化学角度而言,其反应结果并非百分之百起破坏作用,并不可与胃酸重金属盐之副作用相对较。Cancer is an uncontrollable foreign body protein. At present, it is generally believed that the factors of gastric cancer production are mainly caused by the ingestion of organic amines, nitrites, aromatic compounds, molds and the like. This kind of poison does cause abnormal carcinogenesis of the stomach, but from its chemical point of view, the reaction result is not 100% destructive, and it is not comparable to the side effects of heavy metal salts of gastric acid.
酸与金属成盐化学方向结果固定明了,胃酸与重金属成盐为多环多枝盐及大核能盐,它可以迅速破坏胃酸消化功能,并且不易代谢,一旦超微量或时间一长即成症因,重金属进胃致病是毫无疑问。现时人类生态环境恰因人类日常耗能巨大也导致废气废渣,日日数不尽数,这其中最大的恶果即是——每日有不可测的重金属散布地面,为
动植物和水源吸收——最后大量进入人体。The chemical direction of acid and metal salt is fixed. The salt formed by gastric acid and heavy metal is polycyclic multi-branched salt and large nuclear energy salt. It can quickly destroy the gastric acid digestion function and is not easy to metabolize. Once it is ultra-micro or time-long, it is a cause. There is no doubt that heavy metals enter the stomach. At present, the human ecological environment is due to the huge daily energy consumption of human beings, which also leads to waste gas residue. There are not many days and times. The biggest evil result is that there are unpredictable heavy metals scattered on the ground every day.
Animals and plants and water sources absorb – and finally enter the human body in large quantities.
已可推断,正是重金属影响(多环多枝盐及大核能盐)是造成人类胃癌的主要因素,并且,由胃脏形成的异物体蛋白基因也会转移人体其他内脏——癌症移变——最终还会形成该类遗传基因。可以下结论:重金属污染是目前人类伤害最大的因素——如今再不控制,日久必毁人类!It can be inferred that it is the influence of heavy metals (polycyclic multi-branched salt and large nuclear energy salt) that is the main cause of human gastric cancer, and the heterologous protein gene formed by the stomach also transfers other internal organs of the human body - cancer metastasis - - This type of genetic gene will eventually form. It can be concluded that heavy metal pollution is currently the biggest cause of human injury - now no longer controlled, it will destroy humans for a long time!
运用综合化学讨论推断胃酸重金属盐基因特点。The use of comprehensive chemistry discussion to infer the characteristics of gastric acid heavy metal salt genes.
控制人体健康要理就是确保人体水、电、气综合化学物理平衡,那么破坏这类平衡就是伤害人体。显然人体只要接触过于活性或过于死板的化学物质,就会致人于命。这已有多年多次人类惨剧证实。过活者:细菌传染、活性有机胺、氰化盐等,它可以迅速破坏反应人体催化生物酶,导致人体代谢迅速失控以致丧命;过死者:即为重金属活性物,不可控制代谢,日久亦必丧命。The principle of controlling human health is to ensure the comprehensive chemical and physical balance of water, electricity and gas, so destroying this kind of balance means harming the human body. Obviously, if the human body touches a chemical that is too active or too rigid, it will cause death. This has been confirmed many times by human tragedies. Living: bacteria infection, active organic amines, cyanide salts, etc., it can quickly destroy the reaction of human body catalyzed biological enzymes, resulting in rapid loss of control of human metabolism and death; over the dead: that is heavy metal actives, uncontrollable metabolism, long-term must Killed.
胃酸盐化学结构:Gastric acid chemical structure:
可以推断:死板型最伤人的即是Pb盐、As盐,该类化合基因不仅固定型太高不易代谢而且多环多枝更易形成难以控制的多重不良化反应结果。It can be inferred that the most injurious type of dead plate type is Pb salt and As salt. The compound genes are not only fixed and too high to be metabolized, but also multi-ring and multi-branched are more likely to form unsuitable multiple adverse reaction results.
讨论推断重金属盐破坏基因及转移基因:Discuss inferred heavy metal salt destruction genes and transfer genes:
1、如果某支链为结合与胃酸蛋白酶所形成的~COO·链,那么其结果等同于细菌性破坏,并且不易转移,可以较快地形成胃癌;1. If a branch is a ~COO·chain formed by binding to gastric acid protease, the result is equivalent to bacterial destruction, and it is not easy to metastasize, and gastric cancer can be formed relatively quickly;
2、该类支链多以氨基酸为主,可沉滞胃内或转移吸收,转移至肠、肝、胆、肾即形成该处破坏基因,积累成癌;2, this type of branch is mostly based on amino acids, can be stagnant in the stomach or transfer absorption, transfer to the intestine, liver, gallbladder, kidney to form the destruction gene, accumulate into cancer;
3、支链氨基酸分子量小的流动活性高,易转入血脉及肺部,形成该处癌症;3, the molecular weight of the branched chain amino acid is small, the flow activity is high, and it is easy to transfer into the blood and the lungs, forming a cancer there;
4、该类氨基酸盐其实已可明确为有机胺盐,故一旦进入血脉即可增多几类白细胞并且不易置换,形成白血病,这就是人类近阶段白血病迅速提升率之故;4, this kind of amino acid salt can be clearly identified as organic amine salt, so once it enters the bloodstream, it can increase several types of white blood cells and is not easy to replace, forming leukemia, which is the rapid increase rate of leukemia in human proximal stage;
5、从结构而言,砷盐似乎比铅盐破坏度要高,但其实不然,已知:人体新陈代谢必有生子释放,常规而言光子不易进入多层电子云的重金属核内促核,但一旦积累促核便会形成核辐射。C、H、O有机物易吸生生子也易释放生子,体内闷积时间长便易进入铅核,形成致命核辐射!5. In terms of structure, arsenic salt seems to be more destructive than lead salt, but it is not. It is known that human metabolism must be released by human beings. In general, photons are not easy to enter the heavy metal core of multi-layer electron cloud to promote nuclear, but Once accumulated, the nuclear radiation will form. C, H, O organic matter is easy to suck and give birth to children, and it is easy to enter the lead nucleus when the body is stuffy for a long time, forming deadly nuclear radiation!
现时环境由于能耗日多铅污染日重,故于化学物理综合性判定:铅是目前危害人类健康的首要污物。人类必须予以特别控制。At present, due to the daily energy consumption and lead pollution, the environment is comprehensively judged by chemical physics: lead is the primary pollutant that currently harms human health. Humans must be given special control.
综合上述理论发明研讨:药物是人类生存的必需品,现时社会由于进步发展迅速,世上创造了不少食用型药品,为治病救人作出了不少贡献,不可否认;但众多药品在人类食用后造成的危害性副作用也日见增长,应予注意控制!Based on the above theoretical inventions: drugs are essential for human survival. At present, due to the rapid development of society, the world has created a lot of edible drugs, which have made many contributions to the treatment of diseases and save people. It is undeniable. However, the harm caused by many drugs after human consumption Sexual side effects are also growing, and attention should be paid to control!
可否讨论:药物食入治病其根本因素就是控制人体特有之化学物理平衡,以恢复人体原应有稳定状态。但往往由于化学药物其结构或性能不深明可控,那么其危害性也就难以可控。所以如何可控性进行化学制药,本文有所简述。Can it be discussed: The fundamental factor in the treatment of drugs into the disease is to control the unique chemical and physical balance of the human body, in order to restore the body should have a stable state. However, because the structure or performance of chemical drugs is not well controlled, the harm is difficult to control. So how to control the chemical pharmacy, this article has a brief description.
本发明认为如何科学可控药品食用安全少后遗症以及实效治病功能应于如下三方面讨论。The invention believes that how to scientifically control the safe and sequelae of food safety and the effective therapeutic function should be discussed in the following three aspects.
1、食入药物进入人体必需首先具备正常排泄之功能,此点务必予以特别重视。人体病
因往往异常复杂,药物对副作用难控,但只要能正常排泄,就可以有效控制避免其任何副作用。1. Ingestion of drugs into the human body must first have the function of normal excretion. This point must be given special attention. Human disease
Because the treatment is often complicated, the drug is difficult to control the side effects, but as long as it can be excreted normally, it can effectively control to avoid any side effects.
2、化学药物主体结构应以稳定性非裂解型为主,以减少避免其他副作用。2. The main structure of chemical drugs should be based on stable non-lytic type to reduce other side effects.
3、化学药物支链结构可根据不同病因引入特种治疗平衡成份,以达到治病目的。由于主链无害又易排泄,所以即使有莫测异常,也可避免或减少副作用后遗症。3. The chemical drug branch structure can be introduced into special therapeutic balance components according to different causes to achieve therapeutic purposes. Since the main chain is harmless and easy to excrete, even if there is an unpredictable abnormality, side effects sequelae can be avoided or reduced.
结合上述三点讨论结论是:可控药物应即有正付用又尽量避免副作用。Combined with the above three points of discussion, the conclusion is that the controllable drugs should be used immediately and try to avoid side effects.
发明内容:Summary of the invention:
针对现有技术中的上述技术问题,本发明提供了一种有机硅改性丙烯酸聚酯钾盐及制备方法和防癌治癌用途,所述的这种有机硅改性丙烯酸聚酯钾盐及制备方法和防癌治癌用途要解决现有技术中的防治癌症的药物或者保健品的副作用大,效果不佳的技术问题。In view of the above technical problems in the prior art, the present invention provides a silicone-modified acrylic polyester potassium salt, a preparation method thereof, and a cancer prevention and cancer treatment use, the silicone-modified acrylic polyester potassium salt and The preparation method and the anti-cancer and cancer-treating use are to solve the technical problems of the side effects of the drugs or health care products for preventing and treating cancer in the prior art which have large side effects and are not effective.
本发明提供了一种有机硅改性丙烯酸聚酯钾盐,由丙烯酸或其酯类、丙烯有机硅、过硫酸钾、异丙醇、氢氧化钾和去离子水制备而成,所述的丙烯酸或其酯类、丙烯有机硅、过硫酸钾、异丙醇、氢氧化钾和去离子水的质量比为15.0~20.0:0.7~2.0:0.3~1.0:6.0~10.0:8.0~15.0:52.0~70.0。The invention provides a silicone modified acrylic polyester potassium salt prepared from acrylic acid or its esters, propylene silicone, potassium persulfate, isopropanol, potassium hydroxide and deionized water. The mass ratio of its ester, propylene silicone, potassium persulfate, isopropanol, potassium hydroxide and deionized water is 15.0 to 20.0: 0.7 to 2.0: 0.3 to 1.0: 6.0 to 10.0: 8.0 to 15.0: 52.0 to 70.0.
本发明还提供了上述的一种有机硅改性丙烯酸聚酯钾盐的制备方法,The invention also provides a preparation method of the above-mentioned silicone modified acrylic polyester potassium salt,
包括如下步骤:Including the following steps:
1)按照质量百分比称取丙烯酸或其酯类、丙烯有机硅、过硫酸钾、异丙醇、氢氧化钾和去离子水;1) weighing acrylic acid or its esters, propylene silicone, potassium persulfate, isopropanol, potassium hydroxide and deionized water according to the mass percentage;
2)先将去离子水和异丙醇加入一反应釜加热,预热至65~75℃,加入5~15%的K2S2O8,再加热至78~85℃,开始滴加丙烯酸或其酯类、丙烯有机硅和70~80%的K2S2O8,历时1~2小时,滴加反应结束加入剩余之K2S2O8,在85~90℃保温1~2小时,然后冷却至65~75℃,加入KOH调节pH值7.0~8.0,然后于65~75℃开放自然挥气1~2小时,再继续降温至30~50℃,过滤即得有机硅改性丙烯酸聚酯钾盐(简称硅丙盐)。2) First add deionized water and isopropyl alcohol to a reactor for heating, preheat to 65-75 ° C, add 5 ~ 15% K 2 S 2 O 8 , then heat to 78 ~ 85 ° C, start adding acrylic acid Or its esters, propylene silicone and 70-80% K 2 S 2 O 8 , lasting 1 to 2 hours, adding the remaining K 2 S 2 O 8 after the dropwise addition reaction, and keeping the temperature 1 to 2 at 85-90 ° C Hours, then cool to 65 ~ 75 ° C, add KOH to adjust the pH value of 7.0 ~ 8.0, then open at 65 ~ 75 ° C for 1 to 2 hours, then continue to cool to 30 ~ 50 ° C, filtered to obtain silicone modified Acrylic polyester potassium salt (referred to as silicon propane salt).
本发明还提供了上述的有机硅改性丙烯酸聚酯钾盐在制备治疗或者预防癌症的药物或者保健品中的应用。The present invention also provides the use of the above-mentioned silicone-modified acrylic polyester potassium salt in the preparation of a medicament or a health care product for treating or preventing cancer.
本发明还提供了上述的有机硅改性丙烯酸聚酯钾盐作为食品添加剂中的应用。The present invention also provides the use of the above-mentioned silicone-modified acrylic polyester potassium salt as a food additive.
本发明还提供了一种药品或者保健品,由上述的有机硅改性丙烯酸聚酯钾盐、异丙醇和去离子水组成,其中,所述的有机硅改性丙烯酸聚酯钾盐硅丙盐的质量百分比
为5.0%,所述的异丙醇1.0~2.0%,所述的去离子水93.0~94.0%。The invention also provides a medicine or a health care product, which is composed of the above-mentioned silicone-modified acrylic polyester potassium salt, isopropyl alcohol and deionized water, wherein the silicone-modified acrylic polyester potassium salt silicon propane salt Percentage of mass
It is 5.0%, the isopropanol is 1.0 to 2.0%, and the deionized water is 93.0 to 94.0%.
本发明还提供了一种药品或者保健品,由上述的有机硅改性丙烯酸聚酯钾盐和去离子水组成,其中,所述的有机硅改性丙烯酸聚酯钾盐硅丙盐的质量百分比为5.0%,所述的去离子水95.0%。The invention also provides a medicine or a health care product, which is composed of the above-mentioned silicone-modified acrylic polyester potassium salt and deionized water, wherein the mass percentage of the silicone-modified acrylic polyester potassium salt silicon propane salt At 5.0%, the deionized water was 95.0%.
人类创新药物务必结合综合化学探研病症化学起因,并由此针对性制药可控,并减少甚至杜绝其任何副作用。Human innovative drugs must be combined with comprehensive chemistry to explore the chemical causes of the disease, and thus the targeted pharmaceuticals can be controlled, and reduce or even eliminate any side effects.
本发明的防治原理为:The prevention and treatment principle of the present invention is:
1、主体结构:聚丙烯链,性能稳定不易裂解异变,其无危害性,可以通过不同组份调节其软硬性,粘附平滑性等功能。即入人体不易裂解吸收,但其本身却因有有机化合物及长链因素可以吸附多种有机废物——如体内食物、药物裂解的苯、有机碳等废气、废渣,主功效即为物理吸合作用和无机物废渣废物排泄功效;1. Main structure: Polypropylene chain, stable performance, difficult to crack and change, it is harmless, and its soft and hard properties, adhesion smoothness and other functions can be adjusted through different components. It is not easy to crack and absorb in the human body, but it can absorb a variety of organic wastes due to organic compounds and long-chain factors - such as in vivo food, benzene, organic carbon and other waste gas, waste residue, the main function is physical absorption cooperation. Excretion efficiency of wastes with inorganic wastes;
2、~COOK,丙烯酸钾盐支链,性能稳定不易裂解,入人体极易排泄,具有杀菌吸毒以及吸附多种化学基团废物排泄作用,主功效即为范德华功效所致,常规人体食盐可有效排毒杀菌并有活血导流作用,但因其可裂解入体吸取故一旦超度可致化学物理平衡失控导致副作用,但本结构不会为人体吸附,故无副作用,并还具有活血活气导流功能;丙烯酸钾盐,通过特定的酸值设定,以确定水解度及有效排泄快慢度,本结构为负一价盐,达卫生要求。而且,还具有杀菌吸毒吸收废物排泄功能;2, ~COOK, potassium acrylate chain, stable performance is not easy to crack, easy to excrete into the human body, with sterilization and drug absorption and adsorption of a variety of chemical group waste, the main effect is caused by the effect of van der Waals, conventional human salt can be effective Detoxification sterilization and blood circulation, but because it can be lysed into the body, once it exceeds the chemical and physical balance, the side effect is caused by the loss of control. However, this structure will not be absorbed by the human body, so there is no side effect, and it also has the function of promoting blood circulation. The potassium acrylate salt is set by a specific acid value to determine the degree of hydrolysis and the effective rate of excretion. The structure is a negative monovalent salt and meets hygienic requirements. Moreover, it also has the function of sterilizing and absorbing waste absorption;
3、X:活性有机硅–Si(OH)3、Si(OCH3)3,本品药效之本。活性有机硅支链,活性有机硅可以直接反应游离态金属离子,还可以吸附反应氧化物金属,并可以置换反应吸附胃酸类金属盐,是其活性有机硅特有之物理化学功效。3, X: active silicone - Si (OH) 3 , Si (OCH 3 ) 3 , the efficacy of this product. Active silicone branch, active silicone can directly react with free metal ions, can also adsorb reactive oxide metal, and can displace the reaction to adsorb gastric acid metal salts, which is the unique physical and chemical effect of its active silicone.
活性有机硅结合盐:Active silicone binding salt:
一、同铅化合:First, the same as lead:
二、同砷化合:Second, the same as arsenic:
三、同胃酸盐结合与化学置换:Third, with the combination of gastric acid and chemical replacement:
(与胃酸类As盐、Cd盐、Cr盐等成上述同类反应效果)(It has the same reaction effect as the gastric acid As salt, Cd salt, Cr salt, etc.)
故可确定:该支链组份可以避免控制胃酸重金属盐形成基因,又可以吸附或置换胃酸重金属盐排泄,这就是本发明防癌治癌之科学可控要理所在。人类现已知活性有机硅是人体必需生存物料(大多来源于麦豆食物),它可以有效控制矿物类。而食入矿物类的有效功能,即是能控制人体水、电、气等综合平衡。Therefore, it can be determined that the branch component can avoid the control of gastric acid heavy metal salt forming gene, and can also adsorb or replace gastric acid heavy metal salt excretion, which is the scientific controllable reason for the anti-cancer and cancer treatment of the present invention. It is now known that active silicones are essential materials for human body (mostly from wheat bean food), which can effectively control minerals. The effective function of ingesting minerals is to control the overall balance of water, electricity and gas.
4、硅丙盐合成过程可以产生的副产物:4. By-products that can be produced by the synthesis of silicon-propane salt:
a、双链性未反应单体:微量,因开通挥气蒸发,剔除副作用;a, double-stranded unreacted monomer: a small amount, due to the opening of the vapor evaporation, eliminating side effects;
b、氢氧化钾KOH:微量,pH于7.0~7.5,无副作用;b, potassium hydroxide KOH: trace, pH of 7.0 ~ 7.5, no side effects;
c、K2SO8:微量K2S2O8裂解所致本为盐,人体可食用盐药(缓泻剂)等,亦无副作用。c, K 2 SO 8 : The salt is caused by the cleavage of a trace amount of K 2 S 2 O 8 , the human body can be eaten with a salt medicine (a laxative), and there is no side effect.
5、综合结构明确:FT-2016正作用明确,基无副作用。5, the comprehensive structure is clear: FT-2016 is playing a clear role, no side effects.
本发明和已有技术相比,其技术进步是显著的。已越来越明确所知:重金属对人类危害极大!其主要基理即于胃内形成胃酸重金属盐造致现时人类癌症首要多发基因。面对现时现实,如何控制重金属危害,应为人类创药控制的一个明确方向。本发明的有机硅改性丙烯酸聚酯钾盐可以控制重金属毒,因而可以迅速的防治癌症,并且具有保健的作用。The technical progress of the present invention is remarkable compared to the prior art. It has become increasingly clear that heavy metals are extremely harmful to humans! The main reason is that the formation of gastric acid heavy metal salts in the stomach has led to the current multi-gene gene for human cancer. Faced with the current reality, how to control the dangers of heavy metals should be a clear direction for human drug control. The silicone-modified acrylic polyester potassium salt of the present invention can control heavy metal toxicity, thereby rapidly preventing cancer and having a health care function.
实施例1Example 1
FT-2016:一种活性有机硅改性丙烯酸聚酯钾盐(简称硅丙盐),由丙烯酸或其酯类、丙烯有机硅、过硫酸钾(试剂、药级)、异丙醇(试剂、药级)、氢氧化钾(试剂、药级)和去离子水制备而成。所述的丙烯酸或其酯类、丙烯有机硅、过硫酸钾、异丙醇、氢氧化钾、去离子水的质量比为15.0~20.0:0.7~2.0:0.3~1.0:6.0~10.0:8.0~15.0:52.0~70.0。FT-2016: an active silicone modified acrylic polyester potassium salt (referred to as silicon propane salt), from acrylic acid or its esters, propylene silicone, potassium persulfate (reagent, pharmaceutical grade), isopropanol (reagent, Prepared by drug grade), potassium hydroxide (reagent, drug grade) and deionized water. The mass ratio of the acrylic acid or its ester, propylene silicone, potassium persulfate, isopropanol, potassium hydroxide and deionized water is 15.0 to 20.0: 0.7 to 2.0: 0.3 to 1.0: 6.0 to 10.0: 8.0. 15.0: 52.0 to 70.0.
合成方法:先将去离子水和异丙醇加入一个反应釜加热,预热至65~75℃,加入5~15%K2S2O8,再加热至78~85℃,开始滴加丙烯酸或其酯类、丙烯有机硅和70~80%的K2S2O8,历时1~2小时,滴加反应结束加入剩余之K2S2O8,在85~90℃保温1~2小时,然后冷却至65~75℃,加入KOH调节pH值7.0~8.0,然后于65~75℃开放自然挥气1~2小时,再继续降温至30~50℃,过滤即得FT-2016。Synthesis method: first add deionized water and isopropanol to a reactor for heating, preheat to 65-75 ° C, add 5 ~ 15% K 2 S 2 O 8 , then heat to 78 ~ 85 ° C, start adding acrylic acid Or its esters, propylene silicone and 70-80% K 2 S 2 O 8 , lasting 1 to 2 hours, adding the remaining K 2 S 2 O 8 after the dropwise addition reaction, and keeping the temperature 1 to 2 at 85-90 ° C After an hour, then cool to 65-75 ° C, add KOH to adjust the pH value of 7.0-8.0, then open at 65-75 ° C for 1 to 2 hours, then continue to cool to 30 ~ 50 ° C, and filter to obtain FT-2016.
实施例2Example 2
FT-2016A:按质量百分比称取FT-2016、异丙醇和去离子水,质量百分比为:硅丙盐5.0%、异丙醇1.0~2.0%、去离子水93.0~94.0%。先在一个反应容器中加入FT-2016,再加入异丙醇,升温至35~45℃,再加入去离子水,搅拌30~60min,冷却过滤即得。FT-2016A: FT-2016, isopropanol and deionized water were weighed by mass percentage, and the mass percentage was: silicon propyl salt 5.0%, isopropyl alcohol 1.0-2.0%, deionized water 93.0-94.0%. First, add FT-2016 to a reaction vessel, add isopropanol, raise the temperature to 35-45 ° C, add deionized water, stir for 30-60 min, and cool and filter.
实施例3Example 3
FT-2016B:按质量百分比称取FT-2016和去离子水,质量百分比为:硅丙盐5.0%、去离子水95.0%。先将FT-2016集于一个加热器内85~90℃烘烤1~2小时形成粉状硅丙盐,取之兑和去离子水即得。FT-2016B: Weigh FT-2016 and deionized water by mass percentage, the mass percentage is: silicon propyl salt 5.0%, deionized water 95.0%. Firstly, FT-2016 is baked in a heater at 85-90 ° C for 1 to 2 hours to form a powdery silicon propane salt, which is obtained by adding deionized water.
实施例4试用功效Example 4 trial efficacy
FT-2016(FT-2016A、FT-2016B)历时近半年已于多地(上海、广东、香港、台湾、日本等)多人试用效果。(一次饮用5ml/3~7天)FT-2016 (FT-2016A, FT-2016B) has been used in many places (Shanghai, Guangdong, Hong Kong, Taiwan, Japan, etc.) for nearly half a year. (drink 5ml / 3 ~ 7 days)
1、胃有异症者:迅速排泄出深黑色大便(多重金属类),克日即感整体舒畅,日久越来越健康,显著治疗与防患功效;1, the stomach has a heterosexual disease: rapid excretion of dark black stool (multi-metal), the gram is a sense of overall comfort, more and more healthy, significantly treatment and preventive effects;
2、持久便秘者(青年、老人):迅速恢复正常(此效果甚重:克服病因预防多症特别针对青年人);2, persistent constipation (youth, the elderly): quickly return to normal (this effect is very serious: overcome the cause of prevention of multiple diseases especially for young people);
3、帕金森症者(老人):恢复饮食排泄、睡眠通气、胫骨舒畅等状;3, Parkinson's disease (elderly): restore dietary excretion, sleep ventilation, sacral bones and other conditions;
5、管脑梗症者:迅速恢复睡眠、排泄、通气、活动等效果,稍久(1~2月)即减肥、降低高血压、高脂肪等原有症状;5, tube cerebral infarction: rapid recovery of sleep, excretion, ventilation, activities and other effects, a little longer (January to February) that is to lose weight, reduce high blood pressure, high fat and other original symptoms;
6、其他多类症者及常规保健者:均迅速达食泄、活气、眠动等人体舒畅效果。
6, other types of patients and routine health care providers: all quickly reach the effects of food, relaxation, vitality, sleep and other human body.
上述试用者至今正作用明确基无副作用,可见证本发明预计理论及效果。
The above-mentioned trial users have been playing a clear role to date without side effects, and it can be seen that the present invention predicts the theory and effect.
Claims (6)
- 一种有机硅改性丙烯酸聚酯钾盐,其特征在于:由丙烯酸或其酯类、丙烯有机硅、过硫酸钾、异丙醇、氢氧化钾和去离子水制备而成,所述的丙烯酸或其酯类、丙烯有机硅、过硫酸钾、异丙醇、氢氧化钾和去离子水的质量比为15.0~20.0:0.7~2.0:0.3~1.0:6.0~10.0:8.0~15.0:52.0~70.0。A silicone-modified acrylic polyester potassium salt characterized by being prepared from acrylic acid or its esters, propylene silicone, potassium persulfate, isopropanol, potassium hydroxide and deionized water, said acrylic acid The mass ratio of its ester, propylene silicone, potassium persulfate, isopropanol, potassium hydroxide and deionized water is 15.0 to 20.0: 0.7 to 2.0: 0.3 to 1.0: 6.0 to 10.0: 8.0 to 15.0: 52.0 to 70.0.
- 权利要求1所述的一种有机硅改性丙烯酸聚酯钾盐的制备方法,其特征在于包括如下步骤:The method for preparing a silicone-modified acrylic polyester potassium salt according to claim 1, comprising the steps of:1)按照质量百分比称取丙烯酸或其酯类、丙烯有机硅、过硫酸钾、异丙醇、氢氧化钾和去离子水;1) weighing acrylic acid or its esters, propylene silicone, potassium persulfate, isopropanol, potassium hydroxide and deionized water according to the mass percentage;2)先将去离子水和异丙醇加入一反应釜加热,预热至65~75℃,加入5~15%的K2S2O8,再加热至78~85℃,开始滴加丙烯酸或其酯类、丙烯有机硅和70~80%的K2S2O8,历时1~2小时,滴加反应结束加入剩余之K2S2O8,在85~90℃保温1~2小时,然后冷却至65~75℃,加入KOH调节pH值7.0~8.0,然后于65~75℃开放自然挥气1~2小时,再继续降温至30~50℃,过滤即得有机硅改性丙烯酸聚酯钾盐。2) First add deionized water and isopropyl alcohol to a reactor for heating, preheat to 65-75 ° C, add 5 ~ 15% K 2 S 2 O 8 , then heat to 78 ~ 85 ° C, start adding acrylic acid Or its esters, propylene silicone and 70-80% K 2 S 2 O 8 , lasting 1 to 2 hours, adding the remaining K 2 S 2 O 8 after the dropwise addition reaction, and keeping the temperature 1 to 2 at 85-90 ° C Hours, then cool to 65 ~ 75 ° C, add KOH to adjust the pH value of 7.0 ~ 8.0, then open at 65 ~ 75 ° C for 1 to 2 hours, then continue to cool to 30 ~ 50 ° C, filtered to obtain silicone modified Acrylic polyester potassium salt.
- 权利要求1所述的一种有机硅改性丙烯酸聚酯钾盐在制备治疗或者预防癌症的药物或者保健品中的应用。The use of a silicone-modified acrylic polyester potassium salt according to claim 1 for the preparation of a medicament or a health care product for treating or preventing cancer.
- 权利要求1所述的一种有机硅改性丙烯酸聚酯钾盐作为食品添加剂中的应用。Use of a silicone-modified acrylic polyester potassium salt as claimed in claim 1 as a food additive.
- 一种药品或者保健品,其特征在于:由权利要求1所述的有机硅改性丙烯酸聚酯钾盐、异丙醇和去离子水组成,其中,所述的有机硅改性丙烯酸聚酯钾盐硅丙盐的质量百分比为5.0%,所述的异丙醇1.0~2.0%,所述的去离子水93.0~94.0%。A pharmaceutical or health care product comprising: the silicone-modified acrylic polyester potassium salt according to claim 1, isopropanol and deionized water, wherein the silicone-modified acrylic polyester potassium salt The mass percentage of the silicon propane salt is 5.0%, the isopropanol is 1.0 to 2.0%, and the deionized water is 93.0 to 94.0%.
- 一种药品或者保健品,其特征在于:由权利要求1所述的有机硅改性丙烯酸聚酯钾盐和去离子水组成,其中,所述的有机硅改性丙烯酸聚酯钾盐硅丙盐的质量百分比为5.0%,所述的去离子水95.0%。 A pharmaceutical or health care product comprising: the silicone-modified acrylic polyester potassium salt according to claim 1 and deionized water, wherein the silicone-modified acrylic polyester potassium salt silicon propane salt The mass percentage was 5.0% and the deionized water was 95.0%.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610301731.9A CN105837734A (en) | 2016-05-09 | 2016-05-09 | Organosilicone modified acrylic polyester potash, preparation method and application to cancer prevention and treatment |
CN2016103017319 | 2016-05-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2017193458A1 true WO2017193458A1 (en) | 2017-11-16 |
Family
ID=56591568
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2016/087162 WO2017193458A1 (en) | 2016-05-09 | 2016-06-24 | Organosilicone modified acrylic polyester potassium salt and preparation method and use in prevention and treatment of cancer |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN105837734A (en) |
WO (1) | WO2017193458A1 (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001017575A1 (en) * | 1999-09-10 | 2001-03-15 | Sts Biopolymers, Inc. | Graft polymerization of substrate surfaces |
CN1424353A (en) * | 2002-12-19 | 2003-06-18 | 杨慕杰 | Organic sillicon modified acrylic ester/inorganic nano composite emulsion and its preparation |
CN101058625A (en) * | 2007-04-27 | 2007-10-24 | 兰州交通大学 | Composite latex of organic silicon resin and acrylic ester polymers, and preparation method thereof |
CN101096394A (en) * | 2007-06-22 | 2008-01-02 | 中国科学院广州化学研究所 | Siloxane group containing polyacrylic acid material and synthesizing technique thereof |
CN102643385A (en) * | 2012-05-10 | 2012-08-22 | 西北师范大学 | Organic silicon-acrylic ester copolymer emulsion and preparation and application thereof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10323758A1 (en) * | 2003-05-22 | 2004-12-16 | Bauer, Wulf, Dr. | Remedies for internal use, especially against cancer |
CN102977253B (en) * | 2012-11-06 | 2015-02-04 | 中科院广州化学有限公司 | Silicone modified acrylate hybrid emulsion and preparation method and application thereof |
CN105851222B (en) * | 2014-07-21 | 2019-08-23 | 上海惠昌化工厂 | Fruit freshness preserving fruit wax and preparation method thereof |
-
2016
- 2016-05-09 CN CN201610301731.9A patent/CN105837734A/en active Pending
- 2016-06-24 WO PCT/CN2016/087162 patent/WO2017193458A1/en active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001017575A1 (en) * | 1999-09-10 | 2001-03-15 | Sts Biopolymers, Inc. | Graft polymerization of substrate surfaces |
CN1424353A (en) * | 2002-12-19 | 2003-06-18 | 杨慕杰 | Organic sillicon modified acrylic ester/inorganic nano composite emulsion and its preparation |
CN101058625A (en) * | 2007-04-27 | 2007-10-24 | 兰州交通大学 | Composite latex of organic silicon resin and acrylic ester polymers, and preparation method thereof |
CN101096394A (en) * | 2007-06-22 | 2008-01-02 | 中国科学院广州化学研究所 | Siloxane group containing polyacrylic acid material and synthesizing technique thereof |
CN102643385A (en) * | 2012-05-10 | 2012-08-22 | 西北师范大学 | Organic silicon-acrylic ester copolymer emulsion and preparation and application thereof |
Also Published As
Publication number | Publication date |
---|---|
CN105837734A (en) | 2016-08-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102302599A (en) | Chinese medicinal composition for preventing and treating porcine diarrhea | |
CN101068558A (en) | Improved anti-cancer treatment | |
CN101856384B (en) | Liver-protecting combination | |
Abisso et al. | Current progress in molecular hydrogen medication: protective and therapeutic uses of hydrogen against different disease scenarios | |
WO2003101464A1 (en) | Antiinflammatory agent, agent for preventing/ameliorating allergic diseases and functional food | |
US20100189803A1 (en) | Ejaculum of animals as medicinal material and uses thereof in medicaments for treatment of diseases such as tumors, depression, etc. | |
CN111544456A (en) | Probiotic formula and application thereof | |
WO2017193458A1 (en) | Organosilicone modified acrylic polyester potassium salt and preparation method and use in prevention and treatment of cancer | |
CN115463184B (en) | Probiotic-containing composition with sleep promoting function and preparation method and application thereof | |
TW201927831A (en) | Organic silicon-modified acrylic polyester potassium salt, preparation method thereof and uses of anticancer and cancer treatment capable of controlling heavy metal toxicity, thereby rapidly preventing cancer from occurring and having health care functions | |
CN103816531B (en) | Fusion rotein prepares the purposes in medicine, health food or the food treating and/or preventing radiation damage | |
CN1879788A (en) | Virus-clearing capsule | |
CN102240303B (en) | Production method of composite probiotics for preventing and treating intestinal cancer | |
CN101549145B (en) | Nutrient fluid capable of being radio-resistant and reducing side reaction of radiation treatment | |
CN1698691A (en) | Medicine for treating cough due to lung heat/toxin and preparation method thereof | |
CN103202861A (en) | Application of composition of clostridium butyricum and bifidobacterium dual live bacteria preparation and anticancer medicament in preparation of medicament for treating intestinal cancer | |
CN103720778A (en) | Medicine capable of supporting healthy energy and eliminating toxin | |
CN1273533A (en) | I (Robinia Pseudoacacia) lectin and its uses | |
CN106727886A (en) | It is a kind of to treat medicine of liver cancer and its preparation method and application | |
WO2016072507A1 (en) | PROPHYLACTIC OR THERAPEUTIC AGENT FOR PEPTIC ULCER, FOOD ADDITIVE FOR PROPHYLACTIC OR THERAPEUTIC USE, iNOS EXPRESSION INHIBITOR AND COX-2 EXPRESSION INHIBITOR | |
CN101869329B (en) | Life-prolonging cancer-prevention healthcare beverage | |
WO2018148930A1 (en) | Use of nadh or fadh2 in nutritional intervention for cancer patient | |
CN107970437A (en) | Cordyceps sinensis gram oncogene peptide | |
JP6476043B2 (en) | Preventive or therapeutic agent for peptic ulcer, and food additive for prevention or treatment | |
CN110150486A (en) | A kind of feed addictive for preventing and treating the intestines problems such as milking sow constipation diarrhea |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 16901413 Country of ref document: EP Kind code of ref document: A1 |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 16901413 Country of ref document: EP Kind code of ref document: A1 |